Skip to content
★ Sign in to follow
KF

Kristian Fick

Coegin Pharma AB
Total declarations
9
Company
1
▲ Purchases (9 ops.)
€10k
▼ Sales (0 ops.)
—

Latest filing published 30 Mar 2023 for Coegin Pharma AB, €1,283.

Filing timeline

BuySale
Kristian Fick

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kristian Fick: trading record in brief

All filings by Kristian Fick on record concern Coegin Pharma AB. Over a trading history stretching from 10 March 2023 to 21 March 2023, the count stands at 9 filings.

No open-market sale appears; the market trades are 9 purchases worth €10k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The median purchase comes to €1,232. Clusters matter here: 9 out of 9 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 30 March 2023, reports an open-market purchase of €1,283 in Coegin Pharma AB. Filings reach the Finansinspektionen feed a median of 14 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Kristian Fick

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    14,400 SEK18FI-SE
    100,000 shares@ SEK 0.14412.7% of flowAktieISIN SE0014262218FI:csv-fd76104f41456faade5b
    Canonical exit: 14 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    15,010 SEK18FI-SE
    95,000 shares@ SEK 0.15813.0% of flowAktieISIN SE0014262218FI:csv-607b0da51a326ec80001
    Canonical exit: 11 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    7,550 SEK18FI-SE
    50,000 shares@ SEK 0.1516.6% of flowAktieISIN SE0014262218FI:csv-3676dc267f818e1a7acc
    Canonical exit: 13 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    7,500 SEK18FI-SE
    50,000 shares@ SEK 0.156.6% of flowAktieISIN SE0014262218FI:csv-450454956a2cd1404851
    Canonical exit: 13 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    21,300 SEK19FI-SE
    150,000 shares@ SEK 0.14218.9% of flowAktieISIN SE0014262218FI:csv-34f604537e68e52e73ef
    Canonical exit: 15 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    12,825 SEK18FI-SE
    95,000 shares@ SEK 0.13511.2% of flowAktieISIN SE0014262218FI:csv-62c84c504c5dba64d1d5
    Canonical exit: 18 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    4,865 SEK17FI-SE
    35,000 shares@ SEK 0.1394.3% of flowAktieISIN SE0014262218FI:csv-7524de3c4d913920a8f4
    Canonical exit: 19 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    16,320 SEK18FI-SE
    120,000 shares@ SEK 0.13614.5% of flowAktieISIN SE0014262218FI:csv-f6fb4c7c4c13b43cae66
    Canonical exit: 19 Jun 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    14,000 SEK18FI-SE
    100,000 shares@ SEK 0.1412.2% of flowAktieISIN SE0014262218FI:csv-0b1fe997a1361b584de6
    Canonical exit: 8 Jun 2023 (T+90)

9 of 9 declarations